Bubendorf L - Search Results

1

Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer.

Mertz KD, Horcic M, Hailemariam S, D'Antonio A, Dirnhofer S, Hartmann A, Agaimy A, Eppenberger-Castori S, Obermann E, Cathomas G, Bubendorf L. Mertz KD, et al. Among authors: bubendorf l. Hum Pathol. 2013 Dec;44(12):2727-35. doi: 10.1016/j.humpath.2013.07.019. Epub 2013 Sep 26. Hum Pathol. 2013. PMID: 24074533

2

Prognostic significance of Bcl-2 in clinically localized prostate cancer.

Bubendorf L, Sauter G, Moch H, Jordan P, Blöchlinger A, Gasser TC, Mihatsch MJ. Bubendorf L, et al. Am J Pathol. 1996 May;148(5):1557-65. Am J Pathol. 1996. PMID: 8623924 Free PMC article.

3

Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy.

Bubendorf L, Sauter G, Moch H, Schmid HP, Gasser TC, Jordan P, Mihatsch MJ. Bubendorf L, et al. J Pathol. 1996 Apr;178(4):437-41. doi: 10.1002/(SICI)1096-9896(199604)178:4<437::AID-PATH484>3.0.CO;2-4. J Pathol. 1996. PMID: 8691323

4

Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.

Casella R, Bubendorf L, Sauter G, Moch H, Mihatsch MJ, Gasser TC. Casella R, et al. Among authors: bubendorf l. J Urol. 1998 Aug;160(2):406-10. J Urol. 1998. PMID: 9679888

5

Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer.

Bubendorf L, Tapia C, Gasser TC, Casella R, Grunder B, Moch H, Mihatsch MJ, Sauter G. Bubendorf L, et al. Hum Pathol. 1998 Sep;29(9):949-54. doi: 10.1016/s0046-8177(98)90199-x. Hum Pathol. 1998. PMID: 9744310

6

Langerhans cell histiocytosis of the stomach with atypical morphological features.

Terracciano L, Kocher T, Cathomas G, Bubendorf L, Lehmann FS. Terracciano L, et al. Among authors: bubendorf l. Pathol Int. 1999 Jun;49(6):553-6. doi: 10.1046/j.1440-1827.1999.00909.x. Pathol Int. 1999. PMID: 10469399

7

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, Willi N, Gasser TC, Mihatsch MJ. Bubendorf L, et al. Hum Pathol. 2000 May;31(5):578-83. doi: 10.1053/hp.2000.6698. Hum Pathol. 2000. PMID: 10836297

8

Expression patterns of potential therapeutic targets in prostate cancer.

Zellweger T, Ninck C, Bloch M, Mirlacher M, Koivisto PA, Helin HJ, Mihatsch MJ, Gasser TC, Bubendorf L. Zellweger T, et al. Among authors: bubendorf l. Int J Cancer. 2005 Feb 10;113(4):619-28. doi: 10.1002/ijc.20615. Int J Cancer. 2005. PMID: 15472903 Free article.

9

Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer.

Zellweger T, Benz G, Cathomas G, Mihatsch MJ, Sulser T, Gasser TC, Bubendorf L. Zellweger T, et al. Among authors: bubendorf l. Int J Cancer. 2006 Oct 1;119(7):1660-5. doi: 10.1002/ijc.21704. Int J Cancer. 2006. PMID: 16646074 Free article.

10

Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.

Woenckhaus M, Bubendorf L, Dalquen P, Foerster J, Blaszyk H, Mirlacher M, Soler M, Dietmaier W, Sauter G, Hartmann A, Wild PJ. Woenckhaus M, et al. Among authors: bubendorf l. J Clin Pathol. 2007 May;60(5):483-6. doi: 10.1136/jcp.2005.033407. Epub 2006 May 12. J Clin Pathol. 2007. PMID: 16698957 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page